chr17-66688966-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_002737.3(PRKCA):​c.837C>T​(p.Asn279Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00159 in 1,603,624 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0060 ( 14 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 15 hom. )

Consequence

PRKCA
NM_002737.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.75

Publications

2 publications found
Variant links:
Genes affected
PRKCA (HGNC:9393): (protein kinase C alpha) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This kinase has been reported to play roles in many different cellular processes, such as cell adhesion, cell transformation, cell cycle checkpoint, and cell volume control. Knockout studies in mice suggest that this kinase may be a fundamental regulator of cardiac contractility and Ca(2+) handling in myocytes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 17-66688966-C-T is Benign according to our data. Variant chr17-66688966-C-T is described in ClinVar as [Benign]. Clinvar id is 790185.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.75 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00604 (919/152072) while in subpopulation AFR AF = 0.019 (787/41460). AF 95% confidence interval is 0.0179. There are 14 homozygotes in GnomAd4. There are 437 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 919 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKCANM_002737.3 linkc.837C>T p.Asn279Asn synonymous_variant Exon 8 of 17 ENST00000413366.8 NP_002728.2 P17252L7RSM7Q7Z727

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKCAENST00000413366.8 linkc.837C>T p.Asn279Asn synonymous_variant Exon 8 of 17 1 NM_002737.3 ENSP00000408695.3 P17252
PRKCAENST00000578063.5 linkn.837C>T non_coding_transcript_exon_variant Exon 8 of 10 1 ENSP00000462087.1 J3KRN5
PRKCAENST00000284384.6 linkn.*439C>T non_coding_transcript_exon_variant Exon 9 of 15 5 ENSP00000284384.6 J3KN97
PRKCAENST00000284384.6 linkn.*439C>T 3_prime_UTR_variant Exon 9 of 15 5 ENSP00000284384.6 J3KN97

Frequencies

GnomAD3 genomes
AF:
0.00602
AC:
915
AN:
151954
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0189
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00393
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000662
Gnomad OTH
AF:
0.00862
GnomAD2 exomes
AF:
0.00230
AC:
568
AN:
246852
AF XY:
0.00190
show subpopulations
Gnomad AFR exome
AF:
0.0194
Gnomad AMR exome
AF:
0.00255
Gnomad ASJ exome
AF:
0.00260
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00106
Gnomad OTH exome
AF:
0.00249
GnomAD4 exome
AF:
0.00113
AC:
1636
AN:
1451552
Hom.:
15
Cov.:
30
AF XY:
0.00106
AC XY:
769
AN XY:
722332
show subpopulations
African (AFR)
AF:
0.0198
AC:
658
AN:
33222
American (AMR)
AF:
0.00258
AC:
113
AN:
43830
Ashkenazi Jewish (ASJ)
AF:
0.00250
AC:
65
AN:
26020
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39570
South Asian (SAS)
AF:
0.000424
AC:
36
AN:
84872
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53366
Middle Eastern (MID)
AF:
0.0130
AC:
75
AN:
5758
European-Non Finnish (NFE)
AF:
0.000464
AC:
513
AN:
1104898
Other (OTH)
AF:
0.00293
AC:
176
AN:
60016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
70
140
211
281
351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00604
AC:
919
AN:
152072
Hom.:
14
Cov.:
32
AF XY:
0.00588
AC XY:
437
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.0190
AC:
787
AN:
41460
American (AMR)
AF:
0.00393
AC:
60
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10564
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000662
AC:
45
AN:
67996
Other (OTH)
AF:
0.00853
AC:
18
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
46
92
138
184
230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00736
Hom.:
48
Bravo
AF:
0.00708
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00153
EpiControl
AF:
0.00215

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
13
DANN
Benign
0.75
PhyloP100
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150522438; hg19: chr17-64685084; API